McKesson Medical-Surgical wants to help keep you informed of the most current industry Rx shortages. We continue to work with manufacturers to address shortages and to source substitute or alternate products when available.
Top Pharmaceutical News
Availability Update: Kedbumin
Kedrion recently announced that Kedbumin will not be available until 2019 due to supply issues, but will be offering Albuked as a substitute item at the same price.Albuked Package Insert
|Item #||Description||Substitute Item #||Substitute Description|
|890897||Kedbumin 25%, 50mL||1073652||Albuked 25%, 50mL|
|892970||Kedbumin 25%, 100mL||1073653||Albuked 25%, 100mL|
Notice of Recall: Risperidone & Ondansetron (Sandoz)
Sandoz Inc. has implemented a voluntary recall and notice of corrective action after discovering certain blister card packages distributed in the U.S. do not meet U.S. child-resistant packaging requirements, posing a risk of harm if the tablets are swallowed by children. Sandoz expects to resolve the packaging issue by January 2019, and in the meantime a recall has been issued to affected customers and the McKesson item numbers have been discontinued. Please see below for replacement items.
|Recalled Item #||Description||Replacement Item #||Replacement Description|
|1043139||Risperidone ODT tab, 0.5mg UD||1110801||Risperidone ODT tab, 0.5mg UD|
|1059505||Risperidone ODT tab, 2mg UD||1110791||Risperidone ODT tab, 2mg UD|
|1043141||Risperidone ODT tab, 3mg UD||1110802||Risperidone ODT tab, 3mg CAD|
|1059504||Risperidone ODT tab, 4mg UD||1015416||Risperidone ODT tab, 4mg|
|694862||Ondansetron tab, 8mg UD ODT||1110803||Ondansetron tab, 8mg UD OD|
Availability Update: Lidocaine IV Solution
The following B. Braun items have been removed from allocation and are now available.
|214271||Lidocaine, 0.4% IV solution, 5% dextrose, 500mL|
|274052||Lidocaine, 0.4% IV solution, 5% dextrose, 250mL|
Availability Update: Shingrix Vaccine
Due to unprecedented, market-wide demand for Shingrix, GSK has continued ordering limits, backorders and shipping delays at least through the end of 2018. We continue to work closely with GSK to determine product availability.
|Item #||Description||NDC #|
|1080947||Shingrix Vaccine, single dose vial, 50mcg/0.5mL||58160081912|
Top Pharmaceutical Backorders
Xylocaine with Epinephrine & Lidocaine with Epinephrine
Fresenius Kabi is experiencing an increased demand for Xylocaine with Epinephrine, resulting in limited product availability due to the product now being on manufacturer allocation. Pfizer Injectables (Hospira) is currently experiencing manufacturing delays across all presentations of their generic product, Lidocaine with Epinephrine.
|Item #||Description||Estimated Release Date||Availability|
|747088||Lidocaine 1% with Epinephrine, 1:100,000 multiple dose vial, 50mL||August||Limited availability|
|762869||Xylocaine 1% with Epinephrine, 1:100,000 multiple dose vial, 50mL||August||Limited availability|
|767543||Lidocaine 2% with Epinephrine, 1:100,000 multiple dose vial, 50mL||October||Limited availability|
|747065||Lidocaine 1% with Epinephrine, 1:100,000 multiple dose vial, 20mL||August||Limited availability|
|916457||Xylocaine 1% with Epinephrine, 1:100,000 multiple dose vial, 50mL||August||Limited availability|
|767541||Lidocaine 2% with Epinephrine, 1:100,000 multiple dose vial, 20mL||August||Limited availability|
|763949||Xylocaine 1% with Epinephrine, 1:100,000 multiple dose vial, 20mL||August||Limited availability|
|747452||Lidocaine 0.5% with Epinephrine, 1:200,000 multiple dose vial, 50mL||August||Limited availability|
|916166||Xylocaine 2% with Epinephrine, 1:100,000 multiple dose vial, 50mL||Late August||None available|
|863133||Xylocaine 1% with Epinephrine, 1:100,000 multiple dose vial, 10mL||No release date||Limited availability|
|239935||Lidocaine HCl 1%, multiple dose vial, 20mL (25/pk)||August||None available|
|239936||Lidocaine HCl 1%, multiple dose vial, 50mL (25/pk)||August||None available|
|300448||Lidocaine HCl 2%, multiple dose vial, 50mL (25/pk)||September||None available|
|785140||Xylocaine 1%, multiple dose vial, 50mL||Late August||None available|
Other Pharmaceutical Backorders
View Pfizer’s most recent report for next expected delivery and estimated recovery date for Pfizer Injectables (Hospira) products, including emergency syringes and anesthetics (Lidocaine, Marcaine) currently on backorder.
|Item #||Description||Availability||Estimated Release Date||Possible Substitute/Alternative|
|239930||Bacteriostatic Sodium Chloride, 0.9% multiple dose vial, 30mL||None available||September||None available|
|236173||Sodium Chloride Injection, 0.9% flip-top vial, 10mL (25/pk)||Limited availability||September||None available|
|All presentations||Ondanstron HCl, 2mg/mL 2mL single dose vial (10/ct)||Limited availability||Next allocation date TBD||None available|
|508352||Ful-Glo® Ophthalmic Strip, 1mg (100/bx)||None available||Next allocation date TBD||None available|
|1081079||Shingrix® Vaccine, 50mcg/0.5mL single dose vial||Limited availability||August||Item 626032 Zostavax® Shingles single dose vial|
The product information contained in this document, including the product images and additional product materials, was collected from various supplier sources. All product claims and specifications are those of the product suppliers, not McKesson Medical-Surgical or its affiliates (“McKesson”) and have not been independently verified by McKesson. McKesson is not responsible for errors or omissions in the product information.
The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Caution should be exercised when using or purchasing any products from McKesson’s online or print documents by closely examining the product packaging and the labeling prior to use.
Due to product changes, information listed in this document is subject to change without notice. This information is placed solely for your convenience in ordering and McKesson disclaims all responsibility for its completeness and accuracy, whether or not the inaccuracy or incompleteness is due to fault or error by McKesson.